Exchange of Marketing Information. From time-to-time Warner will develop call lists, schedules and other appropriate information for the purpose of determining the physicians and other persons involved in the drug purchase decision-making process to whom LeukoSite and Warner will Detail each Warner-LeukoSite Product in the Designated Co-Promotion Countries. The parties agree to cooperate in finding an inexpensive and expeditious way to provide a call list and other information indicating the identity of those physicians and other persons involved in the decision-making process regarding the purchase of pharmaceuticals. The parties will establish a method of confirming when Details have been made in the Designated Co-Promotion Countries so that, among other things, LeukoSite's and Warner's Detail Effort can be calculated.
Appears in 4 contracts
Samples: Research, Development and Marketing Agreement (Leukosite Inc), Research, Development and Marketing Agreement (Leukosite Inc), Research, Development and Marketing Agreement (Leukosite Inc)